Cart
Free US shipping over $10
Proud to be B-Corp

Pharmacotherapy of Diabetes: New Developments Carl Erik Mogensen

Pharmacotherapy of Diabetes: New Developments By Carl Erik Mogensen

Pharmacotherapy of Diabetes: New Developments by Carl Erik Mogensen


$150.19
Condition - New
Only 2 left

Summary

The treatment of both types 1 and 2 of this disease has changed radically over the past few years. Summarizing all aspects of treatment, this book delineates the large amount of research work that has been completed over the last few years into the relief of complications in diabetes and vascular medicine in general.

Pharmacotherapy of Diabetes: New Developments Summary

Pharmacotherapy of Diabetes: New Developments: Improving Life and Prognosis for Diabetic Patients by Carl Erik Mogensen

Diabetes is a huge and growing healthcare worry, especially in Western countries. The treatment of both types 1 and 2 of this disease has changed radically over the past few years. This work provides an overview of all the changes that will come to be implemented in clinical practice. Summarizing all aspects of treatment, this book delineates the large amount of research work that has been completed over the last few years into the relief of complications in diabetes and vascular medicine in general.

Table of Contents

Overview.- Pharmacoepidemiology of Diabetes.- New Definitions of Diabetes: Consequences.- Pharmacotherapy of Diabetes.- The Insulin Resistance Syndrome: Concept and Therapeutic Approaches.- Medical Emergencies Diabetic Ketoacidosis and Hyperosmolar Hyperglycaemia.- Notes on the Use of Glucagon in Type 1 Diabetes.- Insulin and New Insulin Analogues, Insulin Pumps and Inhaled Insulin in Type 1 Diabetes.- Insulin and New Insulin Analogues with Focus on Type 2 Diabetes.- The Place of Insulin Secretagogues in the Treatment of Type 2 Diabetes in the Twenty-First Century.- Metformin from Devil to Angel.- The Glitazones, Lessons so Far.- Antidiabetic Combination Therapy.- The Incretin Modulators Incretin Mimetics (GLP-1 Receptor Agonists) and Incretin Enhancers (DPP-4 Inhibitors).- The Role of Alpha-Glucosidase Inhibitors (Acarbose).- Multifactorial Intervention in Type 2 Diabetes.- Treating the Comorbid Patient.- Obesity and Pharmacological Treatment.- Management of Diabetic Dyslipidaemia.- Coronary Intervention and Ischemic Cardioprotection in Diabetic Patients.- Diabetic Complications and Side-effects.- ACE-I and ARB and Blood Pressure Lowering, Including Effect on Renal Disease. Treatment of Advanced Diabetic Renal Disease.- Aspirin and Antiplatelet Drugs in the Prevention of Cardiovascular Complications of Diabetes.- Glycosylation Inhibitors, PKC Inhibitors and Related Interventions Against Complications.- Diabetic Foot Ulcers.- Pharmacotherapy in Diabetic Neuropathy.- Pregnancy Pharmacological Problems.- Pharmacotherapy of Diabetic Retinopathy.- Pharmacotherapy in Diabetic Sexual Dysfunction.- A Bone Perspective.- Notes from Major Pharmaceutical Companies (all major companies asked to participate).- Achieving Guideline Control with New Pharmacotherapies: Albumin-Binding by Acylation of Insulin and GLP-1.- Pharmacotherapy of Diabetes.

Additional information

NPB9780387697369
9780387697369
0387697365
Pharmacotherapy of Diabetes: New Developments: Improving Life and Prognosis for Diabetic Patients by Carl Erik Mogensen
New
Hardback
Springer-Verlag New York Inc.
2007-09-05
289
N/A
Book picture is for illustrative purposes only, actual binding, cover or edition may vary.
This is a new book - be the first to read this copy. With untouched pages and a perfect binding, your brand new copy is ready to be opened for the first time

Customer Reviews - Pharmacotherapy of Diabetes: New Developments